Business Description
Patrys Ltd
SIC : 2836
ISIN : AU000000PAB9
Description
Patrys Ltd focuses on the development of natural human antibody-based therapies for the treatment of cancer. The company's product includes Deoxymab 3E10, PAT-SC1, PAT-DX1 PAT-DX1-NP, PAT-DX3, and PAT-LM1. Its main technology is Deoxymab 3E10, a DNA damage repair (DDR) antibody that penetrates live cell nuclei and inhibits key mechanisms of DNA repair in target cancer cells.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.91 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -18.6 | |||||
| 3-Year FCF Growth Rate | -14.5 | |||||
| 3-Year Book Growth Rate | -15.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 40.58 | |||||
| 9-Day RSI | 39.65 | |||||
| 14-Day RSI | 39.86 | |||||
| 6-1 Month Momentum % | -33.33 | |||||
| 12-1 Month Momentum % | -47.37 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 10.38 | |||||
| Quick Ratio | 10.38 | |||||
| Cash Ratio | 5.89 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -23.8 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -70.37 | |||||
| ROA % | -64.12 | |||||
| ROIC % | -267.81 | |||||
| ROC (Joel Greenblatt) % | -499.16 | |||||
| ROCE % | -99.27 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 2.33 | |||||
| EV-to-EBIT | -1.04 | |||||
| EV-to-EBITDA | -1.04 | |||||
| EV-to-FCF | -1.79 | |||||
| Earnings Yield (Greenblatt) % | -96.15 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Patrys Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | |||
| EPS (TTM) (A$) | -0.004 | ||
| Beta | 1.76 | ||
| Volatility % | 71.64 | ||
| 14-Day RSI | 39.86 | ||
| 14-Day ATR (A$) | 0.000536 | ||
| 20-Day SMA (A$) | 0.0076 | ||
| 12-1 Month Momentum % | -47.37 | ||
| 52-Week Range (A$) | 0.007 - 0.034 | ||
| Shares Outstanding (Mil) | 2,057.45 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Patrys Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Patrys Ltd Stock Events
| Event | Date | Price(A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Patrys Ltd Frequently Asked Questions
What is Patrys Ltd(ASX:PAB)'s stock price today?
The current price of ASX:PAB is A$0.01. The 52 week high of ASX:PAB is A$0.03 and 52 week low is A$0.01.
When is next earnings date of Patrys Ltd(ASX:PAB)?
The next earnings date of Patrys Ltd(ASX:PAB) is .
Does Patrys Ltd(ASX:PAB) pay dividends? If so, how much?
Patrys Ltd(ASX:PAB) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers